CARsgen Therapeutics Holdings Limited (2171.HK) HKSE

Currency In HKD

AD

Valuation

Market Cap7.36B
Enterprise Value6.3B
P/E Ratio-74.26
PEG Ratio-0.51
Price/Sales Ratio60.83
Price/Book Ratio9.45
Enterprise/Revenue52.37
Enterprise/EBITDA-36.81

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterDecember 31, 2025

Profitability

Profit Margin-0.78
Operating Margin-0.83
AD

Management Effectiveness

Return On Assets-0.08
Return On Equity-0.11

Income Statement

Revenue125.66M
Revenue/Share0.23
Gross Profit79.95M
EBITDA-203.91M
Net Income-97.86M
Diluted EPS-0.18

Balance Sheet

Total Cash1.12B
Total Cash/Share2.03
Total Debt61.2M
Total Debt/Equity0.08
Current Ratio5.73
Book Value Per Share1.41

Price History

52-Week Change-25.53
52-Week High28.6
52-Week Low10.87
Moving Average 50 Days17.76
Moving Average 200 Days16.99

Statistics

Average Volume6.95M
Shares Outstanding570.27M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A
AD